6 insiders buy $123 mil of Small-Cap

Here are three stocks recently purchased by C-level insiders Here are three stocks recently purchased by C-level insiders                                                                                                      You are receiving this email because you are subscribed to Behind the Markets. If you no longer wish to receive these emails, please [unsubscribe]( here.  Dear Fellow Investor, Investors should always be on the lookout for insights that could give them an edge in the stock market, and one potential source of such information is insider buying activity. When company insiders, such as executives or board members, buy shares of a company's stock, it can be seen as a vote of confidence in the company's prospects. Publicly available insider buying information can provide valuable clues about which stocks may be worth considering for investment. Here are three stocks recently purchased by C-level insiders - Instacart (Maplebear Inc.) – SYM: CART Recent Price: $25.00 Insider Action: 6 insiders buy $123 mil in shares Description: Maplebear Inc., doing business as Instacart, provides online grocery shopping services to households in North America. It sells and delivers a range of products, such as food, alcohol, consumer health, pet care, ready-made meals, and others. The company offers its services through a mobile application and website. It also provides software-as-a-service solutions to retailers. The company was incorporated in 2012 and is based in San Francisco, California. === [R.I.P. for the American Dream? (Surprising answer inside...)]( [dollar]( A record-low happiness level is seeping through the nation's fabric like wildfire. The culprits? The floundering state of the economy…rising housing and rent costs…and inflation. It's called the "opportunity gap", and the bad news is it's only getting wider. BUT THERE IS HOPE...legendary Wall Street fintech experts Andy and Landon Swan have issued a major buy alert for a surprising company making news in the AI space. They have compelling evidence that this Great $2 AI Moonshot could become the #1 tech sensation of the decade. [Go here now for the details.]( === Douglas Elliman Inc. – SYM: DOUG Recent Price: $2.16 [Get Insider Action Here ]( Description: Douglas Elliman Inc. engages in the real estate services and property technology investment business in the United States. It operates in two segments, Real Estate Brokerage, and Corporate and Other. The company conducts residential real estate brokerage operations. It has approximately 120 offices with approximately 6,900 real estate agents in the New York metropolitan areas, as well as in Florida, California, Connecticut, Massachusetts, Colorado, New Jersey, and Texas. Douglas Elliman Inc. was founded in 1911 and is headquartered in Miami, Florida. === [WARNING: Mandatory U.S. Dollar Recall to Begin on November 1st?]( [dollar recall]( If you have any U.S. dollars in your bank account… You must see this shocking video exposing the government’s new plan to recall the U.S. dollar. According to Business Insider, this recall “could be imminent.” And if you don’t prepare now, you could end up holding a bunch of worthless U.S. dollars. [Click here to see the three simple steps you can take now to protect your life savings.]( === Codexis, Inc. – SYM: CDXS Recent Price: $1.97 [Get Insider Action Here ]( Description: Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver protein engineering technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used to discover novel biotherapeutic drug candidates for targeted human diseases, as well as for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California. === [Elon Musk May Have Just Changed Everything]( [host]( A legendary investor just released this shocking footage from the streets of San Francisco. And it reveals Elon Musk's "project Omega." If you don't know what I'm talking about, it's not your fault. The corrupt mainstream media isn't covering this story. But ever American deserves to see what's happening because this is guaranteed to affect all 331 million Americans one way or another. [Click here now and learn how to prepare.]( "The Buck Stops Here" [youtube button]( [facebook button]( [instagram button]( Our mailing address is: Behind the Markets, LLC 4260 NW 1st Avenue, Suite 55 Boca Raton, FL 33431 Copyright © 2023 Behind the Markets, LLC, All rights reserved. You're receiving this email as part of your subscription to Behind the Markets. For more information about our privacy practices, please review our [Privacy Policy]( or our [Legal Notices.]( [Unsubscribe](